Status: Recruiting
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Participants needed: 230
Trial details
Age: 9-64Biological sex: AllType: ObservationalSponsor: Stanford UniversityUpdated: Mar 18, 2026Locations: 1
Eligibility criteria
Age 9 through 64 years [+3]
Received the influenza vaccine less than 4 months ago [+5]